Sayyid RK, Dingar D, Fleshner K, Thorburn T, Diamond J, Yao E, Hersey K, Chadwick K, Perlis N, Klotz L, Finelli A, Hamilton R, Kulkarni G, Zlotta A, Fleshner N. What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?. CUAJ [Internet]. 2017 Apr. 11 [cited 2024 Apr. 30];11(3-4):118-22. Available from: https://cuaj.ca/index.php/journal/article/view/4182